122 related articles for article (PubMed ID: 36262039)
21. ADC similarity predicts microvascular invasion of bifocal hepatocellular carcinoma.
Yang C; Wang H; Tang Y; Rao S; Sheng R; Ji Y; Zeng M
Abdom Radiol (NY); 2018 Sep; 43(9):2295-2302. PubMed ID: 29392365
[TBL] [Abstract][Full Text] [Related]
22. Pre-treatment MRI minimum apparent diffusion coefficient value is a potential prognostic imaging biomarker in cervical cancer patients treated with definitive chemoradiation.
Marconi DG; Fregnani JH; Rossini RR; Netto AK; Lucchesi FR; Tsunoda AT; Kamrava M
BMC Cancer; 2016 Jul; 16():556. PubMed ID: 27469349
[TBL] [Abstract][Full Text] [Related]
23. Diffusion-weighted magnetic resonance imaging predicts survival in patients with liver-predominant metastatic colorectal cancer shortly after selective internal radiation therapy.
Schmeel FC; Simon B; Sabet A; Luetkens JA; Träber F; Schmeel LC; Ezziddin S; Schild HH; Hadizadeh DR
Eur Radiol; 2017 Mar; 27(3):966-975. PubMed ID: 27271923
[TBL] [Abstract][Full Text] [Related]
24. Survival in patients with hepatocellular carcinoma treated with 90Y-microsphere radioembolization. Prediction by 18F-FDG PET.
Sabet A; Ahmadzadehfar H; Bruhman J; Sabet A; Meyer C; Wasmuth JC; Pieper CC; Biersack HJ; Ezziddin S
Nuklearmedizin; 2014; 53(2):39-45. PubMed ID: 24777354
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of pretreatment diffusion-weighted magnetic resonance imaging for outcome prediction of colorectal cancer liver metastases undergoing 90Y-microsphere radioembolization.
Schmeel FC; Simon B; Luetkens JA; Träber F; Meyer C; Schmeel LC; Sabet A; Ezziddin S; Schild HH; Hadizadeh DR
J Cancer Res Clin Oncol; 2017 Aug; 143(8):1531-1541. PubMed ID: 28317063
[TBL] [Abstract][Full Text] [Related]
26. The role of diffusion-weighted magnetic resonance imaging in the treatment response evaluation of hepatocellular carcinoma patients treated with radiation therapy.
Yu JI; Park HC; Lim DH; Choi Y; Jung SH; Paik SW; Kim SH; Jeong WK; Kim YK
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(4):814-21. PubMed ID: 24969795
[TBL] [Abstract][Full Text] [Related]
27. Post-TACE changes in ADC histogram predict overall and transplant-free survival in patients with well-defined HCC: a retrospective cohort with up to 10 years follow-up.
Shaghaghi M; Aliyari Ghasabeh M; Ameli S; Ghadimi M; Hazhirkarzar B; Rezvani Habibabadi R; Khoshpouri P; Pandey A; Pandey P; Kamel IR
Eur Radiol; 2021 Mar; 31(3):1378-1390. PubMed ID: 32894356
[TBL] [Abstract][Full Text] [Related]
28. Prediction of microvascular invasion of hepatocellular carcinoma with preoperative diffusion-weighted imaging: A comparison of mean and minimum apparent diffusion coefficient values.
Zhao J; Li X; Zhang K; Yin X; Meng X; Han L; Zhang X
Medicine (Baltimore); 2017 Aug; 96(33):e7754. PubMed ID: 28816952
[TBL] [Abstract][Full Text] [Related]
29. Utility of volumetric contrast-enhanced and diffusion-weighted MRI in differentiating between common primary hypervascular liver tumors.
Zarghampour M; Fouladi DF; Pandey A; Ghasabeh MA; Pandey P; Varzaneh FN; Khoshpouri P; Shao N; Pan L; Grimm R; Kamel IR
J Magn Reson Imaging; 2018 Oct; 48(4):1080-1090. PubMed ID: 29630756
[TBL] [Abstract][Full Text] [Related]
30. Prognostic Value of Metabolic Parameters of 18F-FDG PET/CT and Apparent Diffusion Coefficient of MRI in Hepatocellular Carcinoma.
Hong CM; Ahn BC; Jang YJ; Jeong SY; Lee SW; Lee J
Clin Nucl Med; 2017 Feb; 42(2):95-99. PubMed ID: 27941378
[TBL] [Abstract][Full Text] [Related]
31.
Jreige M; Mitsakis P; Van Der Gucht A; Pomoni A; Silva-Monteiro M; Gnesin S; Boubaker A; Nicod-Lalonde M; Duran R; Prior JO; Denys A; Schaefer N
Eur J Nucl Med Mol Imaging; 2017 Jul; 44(7):1215-1222. PubMed ID: 28233086
[TBL] [Abstract][Full Text] [Related]
32. Diffusion-weighted imaging for identifying patients at high risk of tumor recurrence following liver transplantation.
Chuang YH; Ou HY; Yu CY; Chen CL; Weng CC; Tsang LL; Hsu HW; Lim WX; Huang TL; Cheng YF
Cancer Imaging; 2019 Nov; 19(1):74. PubMed ID: 31730015
[TBL] [Abstract][Full Text] [Related]
33. Utility of Early Posttreatment PET/CT Evaluation Using FDG or
Reizine E; Chalaye J; Mule S; Regnault H; Perrin C; Calderaro J; Laurent A; Amaddeo G; Kobeiter H; Tacher V; Itti E; Luciani A
AJR Am J Roentgenol; 2022 Feb; 218(2):359-369. PubMed ID: 34494448
[No Abstract] [Full Text] [Related]
34. Value of gadoxetic acid-enhanced MRI and diffusion-weighted imaging in the differentiation of hypervascular hyperplastic nodule from small (<3 cm) hypervascular hepatocellular carcinoma in patients with alcoholic liver cirrhosis: A retrospective case-control study.
Kim SS; Kim SH; Song KD; Choi SY; Heo NH
J Magn Reson Imaging; 2020 Jan; 51(1):70-80. PubMed ID: 31062483
[TBL] [Abstract][Full Text] [Related]
35. [Value of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid enhanced magnetic resonance imaging and diffusion-weighted MR imaging in predicting microvascular invasion in hepatocellular carcinoma and the prognostic significance].
Zhu YJ; Feng B; Wang BZ; Wang S; Ye F; Ma XH; Zhao XM
Zhonghua Zhong Liu Za Zhi; 2021 Mar; 43(3):312-317. PubMed ID: 33752311
[No Abstract] [Full Text] [Related]
36. Relationship of apparent diffusion coefficient to survival for patients with unresectable primary hepatocellular carcinoma after chemoembolization.
Dong S; Ye XD; Yuan Z; Xu LC; Xiao XS
Eur J Radiol; 2012 Mar; 81(3):472-7. PubMed ID: 21296517
[TBL] [Abstract][Full Text] [Related]
37. Baseline apparent diffusion coefficients: Validation study of new predictor of survival in patients with unresectable hepatocellular carcinoma following chemoembolization.
Xu L; Wang S; Wang S; Wang Y; Li W; Lin G; Yuan Z
J Xray Sci Technol; 2021; 29(3):507-516. PubMed ID: 33814481
[TBL] [Abstract][Full Text] [Related]
38. Diffusion Kurtosis MR Imaging versus Conventional Diffusion-Weighted Imaging for Distinguishing Hepatocellular Carcinoma from Benign Hepatic Nodules.
Jia Y; Cai H; Wang M; Luo Y; Xu L; Dong Z; Yan X; Li ZP; Feng ST
Contrast Media Mol Imaging; 2019; 2019():2030147. PubMed ID: 31396023
[TBL] [Abstract][Full Text] [Related]
39. Role of diffusion-weighted imaging in response prediction and evaluation after high dose rate brachytherapy in patients with colorectal liver metastases.
Karim S; Seidensticker R; Seidensticker M; Ricke J; Schinner R; Treitl K; Rübenthaler J; Ingenerf M; Schmid-Tannwald C
Radiol Oncol; 2024 Mar; 58(1):33-42. PubMed ID: 38378033
[TBL] [Abstract][Full Text] [Related]
40. Whole-lesion histogram analysis metrics of the apparent diffusion coefficient: a correlation study with histological grade of hepatocellular carcinoma.
Xu YS; Liu HF; Xi DL; Li JK; Liu Z; Yan RF; Lei JQ
Abdom Radiol (NY); 2019 Sep; 44(9):3089-3098. PubMed ID: 31256226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
